C3 glomerulopathy in children: experience at a resource-limited center
Clinical and Experimental Pediatrics · 15.04.2025 · 68 (4) · 311-318
DOI: 10.3345/cep.2024.01256 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Experimental Pediatrics, erschienen am 15.04.2025. Verfasst von Soumya Reddy und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Nephrology, St. John's Medical College Hospital, St. John's National Academy of Health Sciences, Bengaluru, India. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background
In children, C3 glomerulopathy (C3G) is a heterogeneous disease characterized by diverse clinicopathological profiles and kidney outcomes. However, diagnostic work-up in resource-limited settings is challenging because of the unavailability of complement assays and limited access to electron microscopy or genetic testing.
Purpose
This study aimed to describe the clinicopathological features and response to immunosuppression and evaluate renal outcomes among children with C3G in a resource-limited setting.
Methods
This retrospective cohort study involved a review of the hospital records of 46 children (2013–2021) diagnosed with C3G on kidney biopsy. Their clinical, laboratory, treatment, and outcome details at onset and follow-up were noted.
Results
The mean (standard deviation) age was 9 (4) years. The common presentation was acute nephritis (27 [58.6%]), while 1 in 5 (19.5%) presented with rapidly progressive glomerulonephritis. Focal crescentic glomerulonephritis (14 [30.4%]) was the common histological pattern. Electron microscopy was performed in 22 (47.8%), of which 17 were C3 glomerulonephritis and 4 were dense deposit disease (DDD). None of the patients underwent complement assay or genetic testing. Almost two-thirds (63%) received empirical immunosuppressive therapy, most commonly steroids. Of the 31/46 who completed follow-up (median [interquartile range] duration, 11.5 [6–24] months), 6 (19.4%) demonstrated complete kidney recovery, while the other 25 (80.7%) had kidney sequelae; of them, 5 (16.1%) progressed to end-stage kidney disease and 2 (4.3%) died by the last follow-up.
Conclusion
Pediatric C3G has a variable clinicopathological spectrum, while DDD is less common. Most patients present with glomerulonephritis and significant morbidities. The lack of genetic and C3Nephritic factor testing is a barrier to the comprehensive phenotyping and management of C3G in resource-limited settings.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatric Nephrology, St. John's Medical College Hospital, St. John's National Academy of Health Sciences, Bengaluru, India.
- Department of Laboratory Medicine, Manipal Hospital, Bengaluru, India.
Zitieren
APA
Reddy, S., Ghante, A., Vankalakunti, M., & Vasudevan, A. (2025). C3 glomerulopathy in children: experience at a resource-limited center. Clinical and Experimental Pediatrics, 68(4), 311-318. https://doi.org/10.3345/cep.2024.01256
Vancouver
Reddy S, Ghante A, Vankalakunti M, Vasudevan A. C3 glomerulopathy in children: experience at a resource-limited center. Clinical and Experimental Pediatrics. 2025;68(4):311-318. doi:10.3345/cep.2024.01256
BibTeX
@article{Reddy2025,
author = {Reddy, Soumya and Ghante, Abhishek and Vankalakunti, Mahesha and Vasudevan, Anil},
title = {C3 glomerulopathy in children: experience at a resource-limited center},
journal = {Clinical and Experimental Pediatrics},
year = {2025},
volume = {68},
number = {4},
pages = {311--318},
doi = {10.3345/cep.2024.01256}
}
EUVIMED